These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2402269)

  • 1. Aerosolized amiloride for the treatment of lung disease in cystic fibrosis.
    N Engl J Med; 1990 Oct; 323(14):996-8. PubMed ID: 2402269
    [No Abstract]   [Full Text] [Related]  

  • 2. A pilot study of aerosolized amiloride for the treatment of lung disease in cystic fibrosis.
    Knowles MR; Church NL; Waltner WE; Yankaskas JR; Gilligan P; King M; Edwards LJ; Helms RW; Boucher RC
    N Engl J Med; 1990 Apr; 322(17):1189-94. PubMed ID: 2157983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aerosolized amiloride as treatment of cystic fibrosis lung disease: a pilot study.
    Knowles MR; Church NL; Waltner WE; Yankaskas JR; Gilligan P; King M; Edwards LJ; Helms RW; Boucher RC
    Adv Exp Med Biol; 1991; 290():119-28; discussion 129-32. PubMed ID: 1950741
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of second generation amiloride analogs as therapy for cystic fibrosis lung disease.
    Hirsh AJ; Sabater JR; Zamurs A; Smith RT; Paradiso AM; Hopkins S; Abraham WM; Boucher RC
    J Pharmacol Exp Ther; 2004 Dec; 311(3):929-38. PubMed ID: 15273255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amiloride for lung disease in cystic fibrosis.
    Zahaykevich A
    DICP; 1991 Dec; 25(12):1340-1. PubMed ID: 1815431
    [No Abstract]   [Full Text] [Related]  

  • 6. [Amiloride inhalation therapy in mucoviscidosis].
    Lindemann H
    Monatsschr Kinderheilkd; 1993 May; 141(5):392-4. PubMed ID: 8326957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pilot study of amiloride inhalation in children with cystic fibrosis].
    Riedler J; Huttegger I
    Klin Padiatr; 1992; 204(3):158-62. PubMed ID: 1614182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concentration of inhaled amiloride in cystic fibrosis.
    Viaca A; Bignamini E
    Lancet; 1996 Apr; 347(9008):1126. PubMed ID: 8602105
    [No Abstract]   [Full Text] [Related]  

  • 9. [Amiloride hydrochloride nebulized by oxygen in the treatment of mucoviscidosis].
    Lenoir G; Willemot JM; Pradier J; Broissand C; Silly C; Briend R
    Rev Mal Respir; 1992; 9(6):613-6. PubMed ID: 1470753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amiloride: still a viable treatment option in cystic fibrosis?
    Ratjen F; Bush A
    Am J Respir Crit Care Med; 2008 Dec; 178(12):1191-2. PubMed ID: 19050201
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of the amiloride-sensitive epithelial Na+ channel in the pathogenesis and as a therapeutic target for cystic fibrosis lung disease.
    Mall MA
    Exp Physiol; 2009 Feb; 94(2):171-4. PubMed ID: 19060118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Amiloride inhalation].
    Lindemann H
    Pneumologie; 1996 Dec; 50 Suppl 3():841-4. PubMed ID: 9157440
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacokinetics of amiloride after inhalation and oral administration in adolescents and adults with cystic fibrosis.
    Jones KM; Liao E; Hohneker K; Turpin S; Henry MM; Selinger K; Hsyu PH; Boucher RC; Knowles MR; Dukes GE
    Pharmacotherapy; 1997; 17(2):263-70. PubMed ID: 9085317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cystic fibrosis; pathophysiology of electrolyte transport and potential influence of amiloride].
    Hoekstra MO; van Aalderen WM; Gerritsen J; Knol K; Heymans HS
    Ned Tijdschr Geneeskd; 1992 Oct; 136(43):2117-9. PubMed ID: 1279443
    [No Abstract]   [Full Text] [Related]  

  • 15. [Antibiotics in the treatment of cystic fibrosis].
    Stoppelman MR
    Maandschr Kindergeneeskd; 1969 Oct; 37(4):113-9. PubMed ID: 5345411
    [No Abstract]   [Full Text] [Related]  

  • 16. An alternative aerosol delivery system for amiloride.
    Everard ML; Devadason SG; Sunderland VB; Le Souef PN
    Thorax; 1995 May; 50(5):517-9. PubMed ID: 7597664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The management of cystic fibrosis. Observations on gentamycin when used with other antibiotics in pulmonary infections associated with cystic fibrosis.
    Shwachman H; Khaw KT; Kowalski SM
    Clin Pediatr (Phila); 1975 Dec; 14(12):1115-8. PubMed ID: 1192683
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacological properties of N-(3,5-diamino-6-chloropyrazine-2-carbonyl)-N'-4-[4-(2,3-dihydroxypropoxy)phenyl]butyl-guanidine methanesulfonate (552-02), a novel epithelial sodium channel blocker with potential clinical efficacy for cystic fibrosis lung disease.
    Hirsh AJ; Zhang J; Zamurs A; Fleegle J; Thelin WR; Caldwell RA; Sabater JR; Abraham WM; Donowitz M; Cha B; Johnson KB; St George JA; Johnson MR; Boucher RC
    J Pharmacol Exp Ther; 2008 Apr; 325(1):77-88. PubMed ID: 18218832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term tobramycin therapy in patients with cystic fibrosis and advanced pulmonary disease.
    Paporisz U; Posselt HG; Wönne R; Ristow W; Röser D; Knothe H; Bender SW
    Monogr Paediatr; 1979; 10():31-3. PubMed ID: 460275
    [No Abstract]   [Full Text] [Related]  

  • 20. Antibiotic therapy in cystic fibrosis.
    Med Lett Drugs Ther; 1969 Feb; 11(4):14-5. PubMed ID: 5375095
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.